Patient Characteristics Associated With the Need for Long-Term Treatment in a Child Psychiatry Hospital After the Earthquake in Mexico City

2020 ◽  
pp. 1-3
Author(s):  
Rosa-Elena Ulloa ◽  
Emmanuel Sarmiento
Keyword(s):  
Mexico City ◽  
Child Psychiatry ◽  
Clinical Characteristics ◽  
Patient Characteristics ◽  
Term Treatment ◽  
Health Programs ◽  
Baseline Assessment ◽  
Long Term Treatment ◽  
Mental Health Programs

ABSTRACT Objective: The aim of this study is to determine the demographic and clinical characteristics associated with the need for long-term treatment in a child psychiatry facility. Method: Demographic characteristics, diagnosis, source of referral, time elapsed between the earthquake and the request for care, and the treatment prescribed in the baseline assessment were compared between a group of subjects that required long-term treatment (LTT) and a group that was discharged after a brief intervention (D). Results: A total of 171 patients were seen, and 27% of the subjects required LTT. In general, these subjects were younger, referred from highly affected areas, presented a delay in seeking care, and were mainly diagnosed with anxiety and stress-related disorders. Conclusions: These findings suggest the need for research regarding the design of mental health programs for the early detection of psychopathology after natural disasters in children and adolescents.

scholarly journals Influence of Immunogenicity on the Efficacy of Long-Term Treatment with TNFαBlockers in Rheumatoid Arthritis and Spondyloarthritis Patients

2015 ◽  
Vol 2015 ◽  
pp. 1-10 ◽  
Author(s):  
Inesa Arstikyte ◽  
Giedre Kapleryte ◽  
Irena Butrimiene ◽  
Algirdas Venalis
Keyword(s):  
Rheumatoid Arthritis ◽  
Adverse Events ◽  
Clinical Characteristics ◽  
Term Treatment ◽  
High Serum ◽  
Treatment Discontinuation ◽  
Increased Risk ◽  
Long Term Treatment ◽  
Biologic Drug

Objective. To analyze the clinical relevance of the levels of TNFαblockers and anti-drug antibodies (anti-drug Ab) in patients with rheumatoid arthritis (RA) and spondyloarthritis (SpA) treated with adalimumab (ADA), etanercept (ETA), or infliximab (INF) for a prolonged period of time.Methods. Clinical characteristics (disease activity, and adverse events), serum TNFαblockers, and anti-drug Ab levels were evaluated in 62 RA and 81 SpA patients treated with TNFαblockers for a median of 28 months.Results. Anti-ADA Ab were detected in 1 (4.0%) and anti-INF Ab in 14 out of 57 (24.6%) RA and SpA patients. Patient with anti-ADA Ab and 57.1% patients with anti-INF Ab were considered nonresponders to treatment. Anti-ETA Ab were not found in any of 61 ETA treated patients. Anti-ADA and anti-INF Ab levels differ between responders and nonresponders(P>0.05). Three (5.3%) patients with high serum anti-INF Ab levels developed infusion related reactions. Patients with anti-INF Ab more often required changing to another biologic drug (OR 11.43 (95% CI 1.08–120.93)) and treatment discontinuation (OR 9.28 (95% CI 1.64–52.52)).Conclusion. Patients not responding to treatment had higher serum anti-ADA and anti-INF Ab concentrations. Anti-INF Ab formation is related to increased risk of infusion related reactions, changing to another biologic drug, and treatment discontinuation.

Long-Term Treatment of Patients with Recurrent Unipolar Major Depression: Evidence to Clinical Practice

CNS Spectrums ◽  
2006 ◽  
Vol 11 (S15) ◽  
pp. 4-5 ◽  
Author(s):  
Martin B. Keller
Keyword(s):  
Treatment Strategies ◽  
Patient Characteristics ◽  
Evidence Base ◽  
Term Treatment ◽  
Recurrent Depression ◽  
Long Term Treatment ◽  
Risk Factors For Recurrence ◽  
The Individual ◽  
Term Management

Major depressive disorder (MDD) is almost exclusively recurrent. The vast majority of patients who experience one episode of MDD will eventually experience at least one more episode during their lifetime. The recurrent nature of MDD increases the burden to both the individual and society. Hence, it is imperative that treatment strategies focus on achieving remission acutely, as well as maintaining of remission and preventing recurrence. The articles in this supplement are based on presentations and a dialogue among a group of experts who convened for a roundtable discussion on improving long-term outcomes with antidepressant therapy.Improving long-term treatment of MDD begins with understanding the clinical course of recurrent depression and the ability to recognize those patients who are at greatest risk for recurrence. James H. Kocsis, MD, reviews the course of recurrent depression, emphasizing the tendency for it to progressively worsen. He also discusses patient characteristics and other risk factors for recurrence as well as current recommendations for long-term management of recurrent depression.Although long-term antidepressant maintenance treatment studies are somewhat limited in number, they provide the evidence base that shapes existing guidelines for long-term management of recurrent depression. Michael E. Thase, MD, examines this evidence for the different classes of antidepressants. In addition, Thase reviews evidence for the efficacy of psychotherapy and discusses its potentially important role in long-term depression management.

scholarly journals Pediatric Psoriasis: From New Insights into Pathogenesis to Updates on Treatment

Biomedicines ◽  
2021 ◽  
Vol 9 (8) ◽  
pp. 940
Author(s):  
Hye One Kim ◽  
Seok Young Kang ◽  
Jin Cheol Kim ◽  
Chun Wook Park ◽  
Bo Young Chung
Keyword(s):  
Quality Of Life ◽  
Clinical Characteristics ◽  
Systemic Disease ◽  
Term Treatment ◽  
Off Label ◽  
Long Term Treatment ◽  
Frequent Relapses ◽  
Negative Impacts

Psoriasis is a chronic inflammatory systemic disease primarily affecting the skin, but which often involves considerable comorbidities as well. One-third of psoriasis cases start during childhood. In pediatric psoriasis, an association with several medical comorbidities is also indicated. Furthermore, because of its chronic nature and frequent relapses, psoriatic patients tend to require long-term treatment and experience negative impacts on their quality of life. Considering the different clinical characteristics of pediatric psoriasis, it has recently been presented that the pathogenesis of pediatric psoriasis is distinct from adult psoriasis. Treatment for pediatric psoriasis usually involves the same methods as for adults. However, most treatments in pediatric psoriasis are used off-label and research in this regard is still lacking. Targeted therapies involving newly developed biologics are also increasingly being applied to psoriasis in children. This review summarizes the clinical characteristics of pediatric psoriasis and focuses mainly on the updated concepts of pathogenesis and treatments in pediatric psoriasis. This was undertaken to widen the understanding of these relevant aspects and to provide better management of pediatric psoriasis by clinicians.

Prefrontal cortical thickness and clinical characteristics of long-term treatment response to valproate in bipolar disorder

2021 ◽  
Vol 317 ◽  
pp. 111382
Author(s):  
Alejandra Monserrat Rodríguez-Ramírez ◽  
Valente Cedillo-Ríos ◽  
Claudia Becerra-Palars ◽  
Fátima Meza-Urzúa ◽  
Joanna Jiménez-Pavón ◽  
...  
Keyword(s):  
Bipolar Disorder ◽  
Treatment Response ◽  
Cortical Thickness ◽  
Clinical Characteristics ◽  
Term Treatment ◽  
Prefrontal Cortical ◽  
Long Term Treatment

External auditory canal carcinoma: clinical characteristics and long-term treatment outcomes

2020 ◽  
Vol 277 (10) ◽  
pp. 2709-2720 ◽  
Author(s):  
Pedro Correia-Rodrigues ◽  
Sara Ramalho ◽  
Pedro Montalvão ◽  
Miguel Magalhães
Keyword(s):  
Treatment Outcomes ◽  
External Auditory Canal ◽  
Clinical Characteristics ◽  
Term Treatment ◽  
Long Term Treatment

Hypnotherapy is effective in the long-term treatment of functional dyspepsia

2001 ◽  
Vol 120 (5) ◽  
pp. A115-A115 ◽  
Author(s):  
E CALVERT ◽  
L HOUGHTON ◽  
P COOPER ◽  
P WHORWELL
Keyword(s):  
Functional Dyspepsia ◽  
Term Treatment ◽  
Long Term Treatment

1608: Long-Term Treatment with High Doses of Sildenafil Does Not Up-Regulate the Levels of Phosphodiesterase 5 (Pde5) in the Rat Penis

2004 ◽  
Vol 171 (4S) ◽  
pp. 424-424 ◽  
Author(s):  
Monica G. Ferrini ◽  
Eliane G. Valente ◽  
Jacob Rajfer ◽  
Nestor F. Gonzalez-Cadavid
Keyword(s):  
Term Treatment ◽  
Long Term Treatment ◽  
High Doses ◽  
Phosphodiesterase 5

Long-Term Treatment Outcomes for Heroin Dependence: The 11-Year Follow-Up of the ATOS Study

2013 ◽  
Author(s):  
Christina Marel ◽  
Maree Teesson ◽  
Shane Darke ◽  
Katherine Mills ◽  
Joanne Ross ◽  
...  
Keyword(s):  
Treatment Outcomes ◽  
Term Treatment ◽  
Heroin Dependence ◽  
Long Term Treatment
Sign in / Sign up

Export Citation Format

Share Document